| Customers: Moscow Research Cancer Institute named after P.A. Hertsen (MNII) Product: MISiS and 3D Bioprinting Solutions: a 3D bioprinter in the form of a roborook for use in the operating room in situ Project date: 2022/09 - 2022/12
|
2023: 3D bioprinter animal tests in preclinical lab
Modified by scientists MISIS University bioprinter in a form robohands that can print live cells directly on a patient in the operating room, has successfully passed animal tests in a preclinical laboratory MNII named after P.A. Herzen and is ready for further stages of research. This was Zdrav.Expert announced on September 22, 2023 by representatives of MISIS. This technology of bioprinting in situ, i.e. directly into a defect, in the future may become a progressive therapeutic method, ulcers and burn treatment extensive soft tissue injuries. More. here
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |